# Dried Leaf Artemisia (DLA) Compared to Artemisinin Combination Therapy (ACT) vs Malaria

> **NCT03199755** · PHASE2 · WITHDRAWN · sponsor: **Worcester Polytechnic Institute**

## Conditions studied

- Malaria

## Interventions

- **DRUG:** ACT
- **DRUG:** DLA1
- **DRUG:** DLA2

## Key facts

- **NCT ID:** NCT03199755
- **Lead sponsor:** Worcester Polytechnic Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-08-20
- **Primary completion:** 2018-12-31
- **Final completion:** 2019-10-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Withdrawn in 2018 because clinicians did not follow protocols, issues with communication and also with tablet processing, nearby Ebola outbreak in 2018 (in the N Kivu area) confounded efforts.
- **Last updated:** 2021-10-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03199755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03199755, "Dried Leaf Artemisia (DLA) Compared to Artemisinin Combination Therapy (ACT) vs Malaria". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03199755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*